Andy Pasternak insider trades

Open-market stock purchases and sales by Andy Pasternak, Director at Context Therapeutics Inc, from SEC Form 4 filings since Nov 1, 2019.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTX Context Therapeutics IncBought (not open market)—
Jun 17, 2026KARD Kardigan, IncBought (not open market)—

Companies traded

  • CNTX Context Therapeutics Inc: other filings, last Jun 24, 2026
  • KARD Kardigan, Inc: other filings, last Jun 17, 2026
  • HZNP Horizon Therapeutics Public Ltd Co: 20 sales, last Oct 6, 2023

Get free alerts when Andy Pasternak files a new trade →